The main feature of the Russian coronavirus vaccine, developed by the Chumakov Institute, is that it is not made from individual SARS-CoV-2 antigens, but from a whole inactivated virus. On November 14, Chief Researcher of the Chumakov Institute, Academician of the Russian Academy of Sciences Alexei Egorov spoke about this.
According to the specialist, due to the structure of the vaccine, the best immune response is expected from it. And as a result, the best protection against coronavirus
“It gives a complete set of all antigens of this virus, and this gives a complete set of all antibodies,” Yegorov told URA.RU.
It is expected that the vaccine from the Chumakov Institute will be ready in February 2021.
Currently, in the world, according to WHO, about 200 vaccines for COVID-19 are being developed. The first in the world was the registered Russian vaccine “Sputnik V”. The registration of the second drug became known on October 14. It was named “EpiVacCorona”. The development was carried out by the state scientific center “Vector”.
October 30, General Director of the National Medical Research Center named after V.A. Almazov, Academician of the Russian Academy of Sciences Evgeny Shlyakhto spoke about the preventive measures for COVID-19 and the new vaccine of the St. Petersburg Almazov Center, which is “kefir” based on enterococcus.